<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="pmcid: 7356962 doi: 10.3390/plants9060800plants-09-00800 : Review Aromatic Herbs, Medicinal Plant-Derived" exact="Essential" post="Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses:"/>
 <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract After its recent discovery in patients with serious" exact="pneumonia" post="in Wuhan (China), the 2019 novel coronavirus (2019-nCoV), named"/>
 <result pre="in Wuhan (China), the 2019 novel coronavirus (2019-nCoV), named also" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has spread quickly."/>
 <result pre="Wuhan (China), the 2019 novel coronavirus (2019-nCoV), named also Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has spread quickly. Unfortunately,"/>
 <result pre="(China), the 2019 novel coronavirus (2019-nCoV), named also Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 (SARS-CoV-2), has spread quickly. Unfortunately, no"/>
 <result pre="the 2019 novel coronavirus (2019-nCoV), named also Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 (SARS-CoV-2), has spread quickly. Unfortunately, no drug"/>
 <result pre="Unfortunately, no drug or vaccine for treating human this coronavirus" exact="infection" post="is available yet. Numerous options for controlling or preventing"/>
 <result pre="available yet. Numerous options for controlling or preventing emerging 2019-nCoV" exact="infections" post="may be predicted, including vaccines, interferon therapies, and small-molecule"/>
 <result pre="the existing antiviral treatments frequently lead to the development of" exact="viral" post="resistance combined with the problem of side effects, viral"/>
 <result pre="of viral resistance combined with the problem of side effects," exact="viral" post="re-emergence, and viral dormancy. The pharmaceutical industry is progressively"/>
 <result pre="combined with the problem of side effects, viral re-emergence, and" exact="viral" post="dormancy. The pharmaceutical industry is progressively targeting phytochemical extracts,"/>
 <result pre="these natural products has revealed how they interfere with the" exact="viral" post="life cycle, i.e., during viral entry, replication, assembly, or"/>
 <result pre="how they interfere with the viral life cycle, i.e., during" exact="viral" post="entry, replication, assembly, or discharge, as well as virus-specific"/>
 <result pre="functionally different virus families, including coronaviruses. 2019-nCoV SARS-CoV MERS-CoV COVID-19" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 herbal medicines essential oils"/>
 <result pre="different virus families, including coronaviruses. 2019-nCoV SARS-CoV MERS-CoV COVID-19 Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 herbal medicines essential oils phytochemicals"/>
 <result pre="virus families, including coronaviruses. 2019-nCoV SARS-CoV MERS-CoV COVID-19 Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 herbal medicines essential oils phytochemicals medicinal"/>
 <result pre="families, including coronaviruses. 2019-nCoV SARS-CoV MERS-CoV COVID-19 Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 herbal medicines essential oils phytochemicals medicinal plants"/>
 <result pre="plants antiviral activity 1. Introduction Viruses are responsible for several" exact="infections" post="and diseases comprising cancer, while complex disorders such as"/>
 <result pre="comprising cancer, while complex disorders such as Alzheimerâ€™s illness and" exact="type 1" post="diabetes have also been linked to virus-related infections [1]."/>
 <result pre="while complex disorders such as Alzheimerâ€™s illness and type 1" exact="diabetes" post="have also been linked to virus-related infections [1]. In"/>
 <result pre="and type 1 diabetes have also been linked to virus-related" exact="infections" post="[1]. In addition, due to increased foreign travel and"/>
 <result pre="In addition, due to increased foreign travel and rapid urbanization," exact="infectious" post="outbreaks caused by emerging and re-emerging pathogens, including viruses,"/>
 <result pre="present time, several viruses persist without potent immunization, and only" exact="limited" post="virucidal molecules are approved for clinical use in humans"/>
 <result pre="and were considered extremely important pathogenic viruses in livestock, causing" exact="periodic" post="cold or mild human digestive infections [3]. A new"/>
 <result pre="viruses in livestock, causing periodic cold or mild human digestive" exact="infections" post="[3]. A new human coronavirus (CoV) became notably popular"/>
 <result pre="the time, the suspect virus was quickly recognized as the" exact="Severe" post="Acute Respiratory Syndrome-Coronavirus (SARS-CoV) but did not bear a"/>
 <result pre="time, the suspect virus was quickly recognized as the Severe" exact="Acute" post="Respiratory Syndrome-Coronavirus (SARS-CoV) but did not bear a resemblance"/>
 <result pre="the suspect virus was quickly recognized as the Severe Acute" exact="Respiratory" post="Syndrome-Coronavirus (SARS-CoV) but did not bear a resemblance to"/>
 <result pre="A novel coronavirus has caused severe mortality associated with a" exact="respiratory" post="contagious disease. The virus is named Middle East Respiratory"/>
 <result pre="a respiratory contagious disease. The virus is named Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV). This novel MERS-CoV was first observed"/>
 <result pre="respiratory contagious disease. The virus is named Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV). This novel MERS-CoV was first observed in"/>
 <result pre="December 2019 [8]. The virus was named SARS-CoV-2 and the" exact="disease" post="it causes was named Coronavirus Disease 2019 (abbreviated â€œCOVID-19â€�)."/>
 <result pre="named SARS-CoV-2 and the disease it causes was named Coronavirus" exact="Disease" post="2019 (abbreviated â€œCOVID-19â€�). Early on, several of the patients"/>
 <result pre="The coronavirus group comprises numerous species (Figure 1) and induces" exact="respiratory" post="tract and gastrointestinal infections in vertebrates; however, some CoVs"/>
 <result pre="numerous species (Figure 1) and induces respiratory tract and gastrointestinal" exact="infections" post="in vertebrates; however, some CoVs such as SARS, MERS,"/>
 <result pre="discover potent antivirals for protection from and management of CoV" exact="infection" post="in humans [13]. The novelty of the 2019 novel"/>
 <result pre="people in China and spread to other regions in a" exact="short" post="period. On 30 January, 2020, the World Health Organization"/>
 <result pre="and according to Chinaâ€™s National Health Commissionâ€™s report, 14,488 clinical" exact="infections" post="were found in China, comprising 304 deaths. As we"/>
 <result pre="cruise ship MS Zaandam from Holland America [36]. The COVID-19" exact="viral infection" post="resulted in the deaths of more than 182,000 individuals"/>
 <result pre="ship MS Zaandam from Holland America [36]. The COVID-19 viral" exact="infection" post="resulted in the deaths of more than 182,000 individuals"/>
 <result pre="and is now officially considered to be a pandemic. This" exact="viral infection" post="is considered to be the first pandemic due to"/>
 <result pre="is now officially considered to be a pandemic. This viral" exact="infection" post="is considered to be the first pandemic due to"/>
 <result pre="it is the first time the WHO has called an" exact="infectious" post="outbreak a pandemic since the H1N1 â€œswine fluâ€� in"/>
 <result pre="worried, both with the disturbing degrees of seriousness of the" exact="infection" post="and the dissemination of the disease and with the"/>
 <result pre="of seriousness of the infection and the dissemination of the" exact="disease" post="and with the disturbing degrees of indecision and complacency"/>
 <result pre="including deadly infection. Although clinical reports have shown that most" exact="infections" post="with COVID-19 are mild to date, a recent investigation"/>
 <result pre="of cases. Older individuals and different age groups with serious" exact="chronic" post="medical conditions such as respiratory disease, cardiovascular disease, and"/>
 <result pre="different age groups with serious chronic medical conditions such as" exact="respiratory" post="disease, cardiovascular disease, and diabetes tend to be at"/>
 <result pre="groups with serious chronic medical conditions such as respiratory disease," exact="cardiovascular disease," post="and diabetes tend to be at higher risk of"/>
 <result pre="chronic medical conditions such as respiratory disease, cardiovascular disease, and" exact="diabetes" post="tend to be at higher risk of contracting extreme"/>
 <result pre="efficacy and performance of herbal therapy and phytomedicine for preventing" exact="viral" post="infections was illustrated. As such, different countries, including Algeria,"/>
 <result pre="and performance of herbal therapy and phytomedicine for preventing viral" exact="infections" post="was illustrated. As such, different countries, including Algeria, are"/>
 <result pre="the use of herbal and medicinal plants in fighting SARS-CoV-2" exact="infection" post="[15,16,17,21,22,24,25,26,29,30]. After the outbreak of SARS-CoV, first described in"/>
 <result pre="i.e., glycyrrhizin (Figure 3a), exerts an anti-SARS-CoV effect by stopping" exact="viral" post="replication [18,62]. In another investigation, glycyrrhizin (Glycyrrhiza glabra, Fabaceae"/>
 <result pre="on the Herpes simplex virus (HSV, type I) [67] and" exact="Poliomyelitis" post="virus [68]. Other medicinal herbs and plants and culinary"/>
 <result pre="(Panax ginseng) (Figure 7), the last one through its active" exact="secondary" post="metabolite ginsenoside-Rb1 [31]. One hundred British Columbian aromatic and"/>
 <result pre="(Figure 8) were the most effective against an enteric coronavirus." exact="Respiratory" post="syncytial virus (RSV) was totally blocked by a root"/>
 <result pre="with free radical-scavenging ability and has been able to neutralize" exact="infections" post="of bovine coronavirus [76]. 5. Mode of Antiviral Action"/>
 <result pre="discovered plant formulations that inhibit in vivo and in vitro" exact="viral" post="replication [79,80]. Evidence from the above-mentioned publications and reports"/>
 <result pre="mode of action seems to be through the inhibition of" exact="viral" post="replication [19]. Otherwise, molecules that have an antiviral activity"/>
 <result pre="and do not necessitate repetition to inactivate a virus [81]." exact="Resistance" post="to antiviral compounds is probably caused by mutations created"/>
 <result pre="antiviral compounds is probably caused by mutations created in the" exact="viral" post="genome in the course of replication [82]. It has"/>
 <result pre="natural molecules effectively suppress and deter the early process of" exact="infection" post="by HCoV-229E, including viral penetration and attachment, after co-challenge"/>
 <result pre="and deter the early process of infection by HCoV-229E, including" exact="viral" post="penetration and attachment, after co-challenge with the virus. Natural"/>
 <result pre="to mediate several antiviral mechanisms against SARS-CoV, e.g., inhibition of" exact="viral" post="RNA-dependent RNA polymerase and suppression of the function of"/>
 <result pre="RNA-dependent RNA polymerase and suppression of the function of the" exact="viral" post="3CL protease [53]. Herbal preparations have been used as"/>
 <result pre="efficacious antiviral chemotherapeutics are certain compounds that function on different" exact="viral" post="biosynthetic pathways. In the viral replication cycle, they suppress"/>
 <result pre="compounds that function on different viral biosynthetic pathways. In the" exact="viral" post="replication cycle, they suppress different processes, and therefore little"/>
 <result pre="cycle, they suppress different processes, and therefore little or no" exact="viral" post="progeny is created. These medications may work at small"/>
 <result pre="interact with the membrane shell of enveloped viruses and solubilize" exact="viral" post="structural glycoproteins [17,53,55]. The complex metabolism of natural bioactives"/>
 <result pre="action (Table 2) of these traditional supplements is mainly by" exact="viral" post="replication suppression [17,19,23,26,48]. 6. Phytomedicine and Clinical Trials for"/>
 <result pre="replication suppression [17,19,23,26,48]. 6. Phytomedicine and Clinical Trials for Coronavirus" exact="Infections" post="Chinese medicinal plants may provide additional solutions for COVID-19"/>
 <result pre="suggested a combination of herbal and conventional medicine did not" exact="lower" post="the mortality rate but concluded that it may improve"/>
 <result pre="quality of life, reduce chances of deep lung infiltration, and" exact="lower" post="the dose of medications like corticosteroids [28]. A total"/>
 <result pre="and lower the dose of medications like corticosteroids [28]. A" exact="total" post="of 640 persons with SARS participated in the investigation,"/>
 <result pre="lianqiao (Forsythiae fructus), which has reportedly been used to treat" exact="infections" post="for more than two millennia. The study involves 400"/>
 <result pre="of COVID-19 has been reported. The research presents the molecular" exact="morphology" post="of the virus, potential modes of action inside the"/>
 <result pre="inside the target cells, genomic similarity between COVID-19 and SARS," exact="syndrome" post="similarity between COVID-19, SARS, MERS, and typical flu, existing"/>
 <result pre="clinical research on traditional Chinese medicines to avoid and alleviate" exact="infections" post="in order to provide support to health agencies in"/>
 <result pre="traced back the use of traditional Chinese medicines to circumvent" exact="infectious" post="epidemics and pandemics to ancient times. Based on these"/>
 <result pre="as a cure-all for patients who are especially vulnerable to" exact="skin infection." post="The plant has demonstrated broad-spectrum antibacterial activity and some"/>
 <result pre="medicinal plants play a significant action in the management of" exact="viral pneumonia." post="Further scientific research is required to discover the mechanism"/>
 <result pre="not available for the treatment of several viruses, eliminating these" exact="viral" post="infections seems hard and problematic. However, natural products serve"/>
 <result pre="available for the treatment of several viruses, eliminating these viral" exact="infections" post="seems hard and problematic. However, natural products serve as"/>
 <result pre="new structureâ€&quot;activity relationships, and potent medical and therapeutic approaches against" exact="viral" post="infections. A main problem surrounding antiviral drugs targeting specific"/>
 <result pre="viral infections. A main problem surrounding antiviral drugs targeting specific" exact="viral" post="proteins or genes is the capacity of a virus"/>
 <result pre="[106], oseltamivir-resistant influenza viruses [107], and acyclovir- and nucleoside/nucleotide analog-resistant" exact="hepatitis" post="B viruses [108]. There are several aspects that should"/>
 <result pre="standard medicines, as a multiple-target solution may help diminish the" exact="infection" post="potential of drug-resistant virus strains. We trust that natural"/>
 <result pre="the development and advancement of anti-coronavirus drugs. 8. Conclusions Many" exact="viral" post="infections are still lethal and/or are not yet treatable,"/>
 <result pre="development and advancement of anti-coronavirus drugs. 8. Conclusions Many viral" exact="infections" post="are still lethal and/or are not yet treatable, even"/>
 <result pre="products contain different types of antiviral compounds. A characterization of" exact="secondary" post="metabolites will reveal further health benefits. Therefore, the common"/>
 <result pre="common usage of many traditional medicines for the prevention of" exact="viral" post="infections is warranted. Eventually, the discovery and development of"/>
 <result pre="usage of many traditional medicines for the prevention of viral" exact="infections" post="is warranted. Eventually, the discovery and development of new"/>
 <result pre="published version of the manuscript. Funding This research received no" exact="external" post="funding. Conflicts of Interest The authors declare no conflict"/>
 <result pre="no conflict of interest. Abbreviations ACE2: Angiotensin-Converting Enzyme 2; BCV:" exact="Bovine" post="Coronavirus; CDC: US Centers for Disease Control and Prevention;"/>
 <result pre="Angiotensin-Converting Enzyme 2; BCV: Bovine Coronavirus; CDC: US Centers for" exact="Disease" post="Control and Prevention; CoV: Coronavirus; COVID-19: Coronavirus Disease 2019;"/>
 <result pre="Centers for Disease Control and Prevention; CoV: Coronavirus; COVID-19: Coronavirus" exact="Disease" post="2019; EC50: half maximal effective concentration; EOs: Essential Oils;"/>
 <result pre="COVID-19: Coronavirus Disease 2019; EC50: half maximal effective concentration; EOs:" exact="Essential" post="Oils; H1N1: Hemagglutinin Type 1 and Neuraminidase Type 1;"/>
 <result pre="EC50: half maximal effective concentration; EOs: Essential Oils; H1N1: Hemagglutinin" exact="Type 1" post="and Neuraminidase Type 1; HIV: Human Immunodeficiency Virus; HSV:"/>
 <result pre="concentration; EOs: Essential Oils; H1N1: Hemagglutinin Type 1 and Neuraminidase" exact="Type 1;" post="HIV: Human Immunodeficiency Virus; HSV: Herpes Simplex Virus; IBV:"/>
 <result pre="H1N1: Hemagglutinin Type 1 and Neuraminidase Type 1; HIV: Human" exact="Immunodeficiency" post="Virus; HSV: Herpes Simplex Virus; IBV: Infectious Bronchitis Virus;"/>
 <result pre="1; HIV: Human Immunodeficiency Virus; HSV: Herpes Simplex Virus; IBV:" exact="Infectious" post="Bronchitis Virus; IC50: Median Inhibitory Concentration; MERS-CoV: Middle East"/>
 <result pre="Infectious Bronchitis Virus; IC50: Median Inhibitory Concentration; MERS-CoV: Middle East" exact="Respiratory" post="Syndrome Coronavirus; nsP13: non-structural protein 13; RNA: RiboNucleic Acid;"/>
 <result pre="Bronchitis Virus; IC50: Median Inhibitory Concentration; MERS-CoV: Middle East Respiratory" exact="Syndrome" post="Coronavirus; nsP13: non-structural protein 13; RNA: RiboNucleic Acid; RSV:"/>
 <result pre="Syndrome Coronavirus; nsP13: non-structural protein 13; RNA: RiboNucleic Acid; RSV:" exact="Respiratory" post="Syncytial Virus; SARS-CoV: Severe Acute Respiratory Syndrome-Coronavirus; WHO: World"/>
 <result pre="protein 13; RNA: RiboNucleic Acid; RSV: Respiratory Syncytial Virus; SARS-CoV:" exact="Severe" post="Acute Respiratory Syndrome-Coronavirus; WHO: World Health Organization. References References"/>
 <result pre="13; RNA: RiboNucleic Acid; RSV: Respiratory Syncytial Virus; SARS-CoV: Severe" exact="Acute" post="Respiratory Syndrome-Coronavirus; WHO: World Health Organization. References References 1.VehikK.DabeleaD.The"/>
 <result pre="RNA: RiboNucleic Acid; RSV: Respiratory Syncytial Virus; SARS-CoV: Severe Acute" exact="Respiratory" post="Syndrome-Coronavirus; WHO: World Health Organization. References References 1.VehikK.DabeleaD.The changing"/>
 <result pre="WHO: World Health Organization. References References 1.VehikK.DabeleaD.The changing epidemiology of" exact="type 1" post="diabetes: Why is it going through the roof?Diab. Metabol."/>
 <result pre="Der WerfS.BrodtH.R.BeckerS.BergerA.Identification of a novel coronavirus in patients with severe" exact="acute" post="respiratory syndromeN. Engl. J. Med.20033481967197610.1056/NEJMoa03074712690091 5.LiangG.ChenQ.XuJ.LiuY.LimW.PeirisJ.S.M.DiB.Laboratory diagnosis of four"/>
 <result pre="WerfS.BrodtH.R.BeckerS.BergerA.Identification of a novel coronavirus in patients with severe acute" exact="respiratory" post="syndromeN. Engl. J. Med.20033481967197610.1056/NEJMoa03074712690091 5.LiangG.ChenQ.XuJ.LiuY.LimW.PeirisJ.S.M.DiB.Laboratory diagnosis of four recent"/>
 <result pre="7.ZakiA.M.Van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN. Engl. J. Med.20123671814182010.1056/NEJMoa121172123075143 8.ParaskevisD.KostakiE.G.MagiorkinisG.PanayiotakopoulosG.SourvinosG.TsiodrasS.Full-genome evolutionary analysis"/>
 <result pre="Dis. Model.2020525626332110742 10.GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.YanY.The origin, transmission and clinical therapies on coronavirus" exact="disease" post="2019 (COVID-19) outbreakâ€&quot;an update on the statusMilit. Med. Res.2020711010.1186/s40779-020-00240-0"/>
 <result pre="22.KimD.E.MinJ.S.JangM.S.LeeJ.Y.ShinY.S.ParkC.M.KwonS.Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43" exact="Infection" post="of MRC-5 Human Lung CellsBiomolecules2019969610.3390/biom911069631690059 23.LiS.Y.ChenC.ZhangH.Q.GuoH.Y.WangH.WangL.LiR.S.Identification of natural compounds"/>
 <result pre="antiviral activities against SARS-associated coronavirusAntivir. Res.200567182310.1016/j.antiviral.2005.02.00715885816 24.LiB.Q.FuT.DongyanY.MikovitsJ.A.RuscettiF.W.WangJ.M.Flavonoid baicalin inhibits HIV-1" exact="infection" post="at the level of viral entryBiochem. Biophys. Res. Commun.200027653453810.1006/bbrc.2000.348511027509"/>
 <result pre="Res.200567182310.1016/j.antiviral.2005.02.00715885816 24.LiB.Q.FuT.DongyanY.MikovitsJ.A.RuscettiF.W.WangJ.M.Flavonoid baicalin inhibits HIV-1 infection at the level of" exact="viral" post="entryBiochem. Biophys. Res. Commun.200027653453810.1006/bbrc.2000.348511027509 25.LiX.Q.SongY.N.WangS.J.RahmanK.ZhuJ.Y.ZhangH.Saikosaponins: A review of pharmacological"/>
 <result pre="Complement. Med.20144243510.4103/2225-4110.124335 28.LiuX.ZhangM.HeL.LiY.Chinese herbs combined with Western medicine for severe" exact="acute" post="respiratory syndrome (SARS)Cochr. Database. Syst. Rev.20121014410.1002/14651858.CD004882.pub3 29.McCutcheonA.R.RobertsT.E.GibbonsE.EllisS.M.BabiukL.A.HancockR.E.W.TowersG.H.N.Antiviral screening of"/>
 <result pre="Med.20144243510.4103/2225-4110.124335 28.LiuX.ZhangM.HeL.LiY.Chinese herbs combined with Western medicine for severe acute" exact="respiratory" post="syndrome (SARS)Cochr. Database. Syst. Rev.20121014410.1002/14651858.CD004882.pub3 29.McCutcheonA.R.RobertsT.E.GibbonsE.EllisS.M.BabiukL.A.HancockR.E.W.TowersG.H.N.Antiviral screening of British"/>
 <result pre="28.LiuX.ZhangM.HeL.LiY.Chinese herbs combined with Western medicine for severe acute respiratory" exact="syndrome" post="(SARS)Cochr. Database. Syst. Rev.20121014410.1002/14651858.CD004882.pub3 29.McCutcheonA.R.RobertsT.E.GibbonsE.EllisS.M.BabiukL.A.HancockR.E.W.TowersG.H.N.Antiviral screening of British Columbian"/>
 <result pre="of British Columbian medicinal plantsJ. Ethnopharmacol.19954910111010.1016/0378-8741(95)90037-38847882 30.TsaiY.C.LeeC.L.YenH.R.ChangY.S.LinY.P.HuangS.H.LinC.W.Antiviral Action of Tryptanthrin" exact="Isolated" post="from Strobilanthes cusia Leaf against Human Coronavirus NL63Biomolecules20201036610.3390/biom10030366 31.WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.E.LiangF.S.Small"/>
 <result pre="cusia Leaf against Human Coronavirus NL63Biomolecules20201036610.3390/biom10030366 31.WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.E.LiangF.S.Small molecules targeting severe" exact="acute" post="respiratory syndrome human coronavirusProc. Nat. Acad. Sci. USA2004101100121001710.1073/pnas.040359610115226499 32.YangY.IslamM.S.WangJ.LiY.ChenX.Traditional"/>
 <result pre="Leaf against Human Coronavirus NL63Biomolecules20201036610.3390/biom10030366 31.WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.E.LiangF.S.Small molecules targeting severe acute" exact="respiratory" post="syndrome human coronavirusProc. Nat. Acad. Sci. USA2004101100121001710.1073/pnas.040359610115226499 32.YangY.IslamM.S.WangJ.LiY.ChenX.Traditional Chinese"/>
 <result pre="against Human Coronavirus NL63Biomolecules20201036610.3390/biom10030366 31.WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.E.LiangF.S.Small molecules targeting severe acute respiratory" exact="syndrome" post="human coronavirusProc. Nat. Acad. Sci. USA2004101100121001710.1073/pnas.040359610115226499 32.YangY.IslamM.S.WangJ.LiY.ChenX.Traditional Chinese medicine"/>
 <result pre="review and perspectiveInt. J. Biol. Sci.202016170810.7150/ijbs.4553832226288 33.BoukhatemM.N.Effective Antiviral Activity of" exact="Essential" post="Oils and their Characteristics Terpenes against Coronaviruses: An UpdateJ."/>
 <result pre="Terpenes against Coronaviruses: An UpdateJ. Pharmacol. Clin. Toxicol.202081138 34.BoukhatemM.N.Novel Coronavirus" exact="Disease" post="2019 (COVID-19) Outbreak in Algeria: A New Challenge for"/>
 <result pre="online: www.worldometers.info/coronavirus/(accessed on 23 May 2020) 37.GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.DuB.Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaN. Engl. J. Med.20203821708172010.1056/NEJMoa200203232109013 38.ZhengY.Y.MaY.T.ZhangJ.Y.XieX.COVID-19 and the"/>
 <result pre="disease 2019 in ChinaN. Engl. J. Med.20203821708172010.1056/NEJMoa200203232109013 38.ZhengY.Y.MaY.T.ZhangJ.Y.XieX.COVID-19 and the" exact="cardiovascular" post="systemNat. Rev. Cardiol.20201725926010.1038/s41569-020-0360-532139904 39.collab: The Novel Coronavirus Pneumonia Emergency"/>
 <result pre="and the cardiovascular systemNat. Rev. Cardiol.20201725926010.1038/s41569-020-0360-532139904 39.collab: The Novel Coronavirus" exact="Pneumonia" post="Emergency Response Epidemiology TeamThe epidemiological characteristics of an outbreak"/>
 <result pre="Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related" exact="Respiratory" post="Tract Infections in the SpotlightMolecules202025187610.3390/molecules2508187632325742 46.ShenY.C.WangL.T.KhalilA.T.ChiangL.C.ChengP.W.Bioactive pyranoxanthones from the"/>
 <result pre="of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory" exact="Tract" post="Infections in the SpotlightMolecules202025187610.3390/molecules2508187632325742 46.ShenY.C.WangL.T.KhalilA.T.ChiangL.C.ChengP.W.Bioactive pyranoxanthones from the roots"/>
 <result pre="Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract" exact="Infections" post="in the SpotlightMolecules202025187610.3390/molecules2508187632325742 46.ShenY.C.WangL.T.KhalilA.T.ChiangL.C.ChengP.W.Bioactive pyranoxanthones from the roots of"/>
 <result pre="from Pelargonium sidoides, on replication of a broad panel of" exact="respiratory" post="virusesPhytomedicine20111838438610.1016/j.phymed.2010.09.00821036571 48.YiL.LiZ.YuanK.QuX.ChenJ.WangG.ChenL.Small molecules blocking the entry of severe acute"/>
 <result pre="of respiratory virusesPhytomedicine20111838438610.1016/j.phymed.2010.09.00821036571 48.YiL.LiZ.YuanK.QuX.ChenJ.WangG.ChenL.Small molecules blocking the entry of severe" exact="acute" post="respiratory syndrome coronavirus into host cellsJ. Virol.200478113341133910.1128/JVI.78.20.11334-11339.200415452254 49.LoizzoM.R.SaabA.M.TundisR.StattiG.A.MenichiniF.LamprontiI.DoerrH.W.Phytochemical analysis"/>
 <result pre="respiratory virusesPhytomedicine20111838438610.1016/j.phymed.2010.09.00821036571 48.YiL.LiZ.YuanK.QuX.ChenJ.WangG.ChenL.Small molecules blocking the entry of severe acute" exact="respiratory" post="syndrome coronavirus into host cellsJ. Virol.200478113341133910.1128/JVI.78.20.11334-11339.200415452254 49.LoizzoM.R.SaabA.M.TundisR.StattiG.A.MenichiniF.LamprontiI.DoerrH.W.Phytochemical analysis and"/>
 <result pre="virusesPhytomedicine20111838438610.1016/j.phymed.2010.09.00821036571 48.YiL.LiZ.YuanK.QuX.ChenJ.WangG.ChenL.Small molecules blocking the entry of severe acute respiratory" exact="syndrome" post="coronavirus into host cellsJ. Virol.200478113341133910.1128/JVI.78.20.11334-11339.200415452254 49.LoizzoM.R.SaabA.M.TundisR.StattiG.A.MenichiniF.LamprontiI.DoerrH.W.Phytochemical analysis and in"/>
 <result pre="16 June 2020) 67.Renard-NozakiJ.KimT.ImakuraY.KiharaM.KobayashiS.Effect of alkaloids isolated from Amaryllidaceae on" exact="herpes" post="simplex virusRes. Virol.198914011512810.1016/S0923-2516(89)80089-52547235 68.IevenM.VlietinickA.J.BergheD.V.TotteJ.DommisseR.EsmansE.AlderweireldtF.Plant antiviral agents. III. Isolation of"/>
 <result pre="and HSV-2 in cell culturePlanta Med.2005711123112710.1055/s-2005-87317516395648 82.SchnitzlerP.KochC.ReichlingJ.Susceptibility of drug-resistant clinical" exact="herpes" post="simplex virus type 1 strains to essential oils of"/>
 <result pre="cell culturePlanta Med.2005711123112710.1055/s-2005-87317516395648 82.SchnitzlerP.KochC.ReichlingJ.Susceptibility of drug-resistant clinical herpes simplex virus" exact="type 1" post="strains to essential oils of ginger, thyme, hyssop, and"/>
 <result pre="plant terpenoids and lignoids possess potent antiviral activities against severe" exact="acute" post="respiratory syndrome coronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 92.HoT.Y.WuS.L.ChenJ.C.LiC.C.HsiangC.Y.Emodin blocks the SARS"/>
 <result pre="terpenoids and lignoids possess potent antiviral activities against severe acute" exact="respiratory" post="syndrome coronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 92.HoT.Y.WuS.L.ChenJ.C.LiC.C.HsiangC.Y.Emodin blocks the SARS coronavirus"/>
 <result pre="and lignoids possess potent antiviral activities against severe acute respiratory" exact="syndrome" post="coronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 92.HoT.Y.WuS.L.ChenJ.C.LiC.C.HsiangC.Y.Emodin blocks the SARS coronavirus spike"/>
 <result pre="vitro and in vivoJ. Agr. Food. Chem.2012603947395410.1021/jf205158722400806 96.SunQ.ChenL.GaoM.JiangW.ShaoF.LiJ.YuB.Ruscogenin inhibits lipopolysaccharide-induced" exact="acute" post="lung injury in mice: Involvement of tissue factor, inducible"/>
 <result pre="synthase and nuclear factor (NF)-ÎºBInt. Immunopharmacol.201212889310.1016/j.intimp.2011.10.01822079591 97.ChenC.ZuckermanD.M.BrantleyS.SharpeM.ChildressK.HoiczykE.PendletonA.R.Sambucus nigra extracts inhibit" exact="infectious" post="bronchitis virus at an early point during replicationBMC Veter."/>
 <result pre="and nuclear factor (NF)-ÎºBInt. Immunopharmacol.201212889310.1016/j.intimp.2011.10.01822079591 97.ChenC.ZuckermanD.M.BrantleyS.SharpeM.ChildressK.HoiczykE.PendletonA.R.Sambucus nigra extracts inhibit infectious" exact="bronchitis" post="virus at an early point during replicationBMC Veter. Res.2014102410.1186/1746-6148-10-2424433341"/>
 <result pre="an early point during replicationBMC Veter. Res.2014102410.1186/1746-6148-10-2424433341 98.ChenH.MuhammadI.ZhangY.RenY.ZhangR.HuangX.AbbasG.Antiviral Activity Against" exact="Infectious" post="Bronchitis Virus and Bioactive Components of Hypericum perforatum L.Front."/>
 <result pre="102.LuoH.TangQ.L.ShangY.X.LiangS.B.YangM.RobinsonN.LiuJ.P.Can Chinese medicine be used for prevention of corona virus" exact="disease" post="2019 (COVID-19)?A review of historical classics, research evidence and"/>
 <result pre="107.CollinsP.J.HaireL.F.LinY.P.LiuJ.RussellR.J.WalkerP.A.GamblinS.J.Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutantsNature20084531258126110.1038/nature0695618480754 108.DelaneyW.E.IVBorroto-EsodaK.Therapy of" exact="chronic hepatitis" post="B: Trends and developmentsCurr. Opinion. Pharmacol.2008853254010.1016/j.coph.2008.09.008 109.AsresK.BucarF.KartnigT.WitvrouwM.PannecouqueC.De ClercqE.Antiviral activity"/>
 <result pre="structures of oseltamivir-resistant influenza virus neuraminidase mutantsNature20084531258126110.1038/nature0695618480754 108.DelaneyW.E.IVBorroto-EsodaK.Therapy of chronic" exact="hepatitis" post="B: Trends and developmentsCurr. Opinion. Pharmacol.2008853254010.1016/j.coph.2008.09.008 109.AsresK.BucarF.KartnigT.WitvrouwM.PannecouqueC.De ClercqE.Antiviral activity"/>
 <result pre="Trends and developmentsCurr. Opinion. Pharmacol.2008853254010.1016/j.coph.2008.09.008 109.AsresK.BucarF.KartnigT.WitvrouwM.PannecouqueC.De ClercqE.Antiviral activity against human" exact="immunodeficiency" post="virus type 1 (HIV-1) and type 2 (HIV-2) of"/>
 <result pre="developmentsCurr. Opinion. Pharmacol.2008853254010.1016/j.coph.2008.09.008 109.AsresK.BucarF.KartnigT.WitvrouwM.PannecouqueC.De ClercqE.Antiviral activity against human immunodeficiency virus" exact="type 1" post="(HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian"/>
 <result pre="ClercqE.Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and" exact="type 2" post="(HIV-2) of ethnobotanically selected Ethiopian medicinal plantsPhytother. Res.200115626910.1002/1099-1573(200102)15:1&amp;lt;62::AID-PTR956&amp;gt;3.0.CO;2-X11180526 110.HudsonJ.B.Antiviral"/>
 <result pre="(CSSE; FT research; Updated: 17 March 2020, 10:00 GMT). SARS," exact="Severe" post="Acute Respiratory Syndrome, MERS, Middle East Respiratory Syndrome Coronavirus,"/>
 <result pre="FT research; Updated: 17 March 2020, 10:00 GMT). SARS, Severe" exact="Acute" post="Respiratory Syndrome, MERS, Middle East Respiratory Syndrome Coronavirus, nCov,"/>
 <result pre="research; Updated: 17 March 2020, 10:00 GMT). SARS, Severe Acute" exact="Respiratory" post="Syndrome, MERS, Middle East Respiratory Syndrome Coronavirus, nCov, novel"/>
 <result pre="10:00 GMT). SARS, Severe Acute Respiratory Syndrome, MERS, Middle East" exact="Respiratory" post="Syndrome Coronavirus, nCov, novel coronavirus. Î±: Alpha; Î²: Beta;"/>
 <result pre="GMT). SARS, Severe Acute Respiratory Syndrome, MERS, Middle East Respiratory" exact="Syndrome" post="Coronavirus, nCov, novel coronavirus. Î±: Alpha; Î²: Beta; Î³:"/>
 <result pre="isolated pure compounds against different strains of coronavirus (Cov). SARS," exact="Severe" post="Acute Respiratory Syndrome. Coronavirus Strains Plant Species or Isolated"/>
 <result pre="pure compounds against different strains of coronavirus (Cov). SARS, Severe" exact="Acute" post="Respiratory Syndrome. Coronavirus Strains Plant Species or Isolated Compound"/>
 <result pre="compounds against different strains of coronavirus (Cov). SARS, Severe Acute" exact="Respiratory" post="Syndrome. Coronavirus Strains Plant Species or Isolated Compound References"/>
 <result pre="SARS, Severe Acute Respiratory Syndrome. Coronavirus Strains Plant Species or" exact="Isolated" post="Compound References SARS-CoV Lycoris radiata Li et al. [23]"/>
 <result pre="al. [43] Lonicera japonicaEucalyptus spp.Panax ginseng Wu et al. [31]" exact="Bovine" post="coronavirus (BCV) Amelanchier alnifoliaCardamine angulataRosa nutkanaVerbascum Thapsus McCutcheon et"/>
 <result pre="found in: Glycyrrhiza radix Hoever et al. [18] Laurus nobilis" exact="Essential" post="oil fGentiana scabra Loizzo et al. [49] SARS-CoV PUMC01"/>
 <result pre="or pacific serviceberry or western serviceberry - Luteolin Blocking the" exact="viral" post="entry of HIV-luc/SARS pseudo-type virus. 9.02 Î¼M Yi et"/>
 <result pre="[48] Lycoris radiata Red spider lily Inhibition or reduction of" exact="viral" post="attachment and penetration. 2.4 Â± 0.2 Î¼g/mL Li et"/>
 <result pre="Artemisia annua Sweet wormwood 34.5 Â± 2.6 Î¼g/mL Pyrrosia lingua" exact="Tongue" post="Fern 43.2 Â± 14.1 Î¼g/mL Lindera aggregata Spicewood 88.2"/>
 <result pre="Bupleurum marginatum Margined Chinese Thoroughwax Interfering with early stages of" exact="viral" post="replication, such as the penetration of the virus into"/>
 <result pre="flavonoids are metabolized within the body into phenolate ions, inhibiting" exact="viral" post="polymerase function, and connecting with viral nucleic acid or"/>
 <result pre="into phenolate ions, inhibiting viral polymerase function, and connecting with" exact="viral" post="nucleic acid or viral cuspid proteins. That tends to"/>
 <result pre="viral polymerase function, and connecting with viral nucleic acid or" exact="viral" post="cuspid proteins. That tends to lead to viral replication"/>
 <result pre="acid or viral cuspid proteins. That tends to lead to" exact="viral" post="replication being inhibited or reduced. - Cheng et al."/>
 <result pre="lymphocytes. - Yuan et al. [90] Saikosaponins B2 Inhibition of" exact="viral" post="attachment and penetration steps of HCoV-22E9. 1.7 Â± 0.1"/>
 <result pre="cordata Fish mint or Chameleon-plant Inhibition of 3CL-like protease and" exact="viral" post="polymerase, and RNA-dependent RNA polymerase (RdRp) which are key"/>
 <result pre="proportion of CD4+ and CD8+ T cells necessary to fight" exact="viral infection." post="- Lau et al. [53]Kumar et al. [93] Torreya"/>
 <result pre="Great Mullein or Common mullein Active ingredients decrease inflammation during" exact="respiratory" post="infection. - Speranza et al. [94] Herbal extracts (Gentiana"/>
 <result pre="inflammatory injury by the active ingredient (Ruscogenin, steroid sapogenin).Decreases of" exact="cerebral" post="ischemia-induced bloodâ€&quot;brain barrier dysfunction.Anti-inflammatory and anti-thrombotic properties. - Sun"/>
 <result pre="or common Saint Johnâ€™s wort Inhibition of mRNA expression in" exact="Avian" post="coronavirus infectious bronchitis virus (IBV). Chen et al. [98]"/>
 <result pre="Saint Johnâ€™s wort Inhibition of mRNA expression in Avian coronavirus" exact="infectious" post="bronchitis virus (IBV). Chen et al. [98] Sambucus formosana"/>
 <result pre="Johnâ€™s wort Inhibition of mRNA expression in Avian coronavirus infectious" exact="bronchitis" post="virus (IBV). Chen et al. [98] Sambucus formosana Blue"/>
 <result pre="chicken coronavirus strain and coronavirus NL63 by interfering with the" exact="viral" post="envelopes, rendering them non-infectious. - Weng et al. [58]"/>
</results>
